Cancer-associated thrombosis

Por Kakkar, A K
Publicado em 2010

Urokinase receptor is a key player in tumour progression

Por TANIGUCHI, T, LEMOINE, N, KAKKAR, A
Publicado em 1998

Antithrombotic therapy and survival in patients with malignant disease

Por Kakkar, A K, Macbeth, F
Publicado em 2010

Antithrombotic therapy in cancer : Low molecular weight heparins may have a direct effect on tumours 

Por Kakkar, A K, Williamson, R C N
Publicado em 1999

Analysis of the outcome of liver transplantation patients in india - a prospective observational study

Por Jakkinaboina, S, Varma, M, Kakkar, A, Peddapyata, P, Aleem, M, Paul, S
Publicado no Intensive Care Med Exp (2015)

Small Cell Carcinoma of the Renal Pelvis: A Case Report and Review of the Literature

Por Patil, Sachin, Kaza, R. C. M., Kakkar, A. K., Chamberlain, Ronald S.
Publicado em 2011

Identification of a thrombin receptor with factor Xa receptor and tissue factor in human pancreatic carcinoma cells

Por Kakkar, A K, Lemoine, N R, Stone, S R, Altieri, D, Williamson, R C N
Publicado em 1995

Genomic heterogeneity in synchronous hepatocellular carcinomas

Por Sirivatanauksorn, Y, Sirivatanauksorn, V, Bhattacharya, S, Davidson, B, Dhillon, A, Kakkar, A, Williamson, R, Lemoine, N
Publicado em 1999

A Phase I study of the angiogenesis inhibitor SU5416 (semaxanib) in solid tumours, incorporating dynamic contrast MR pharmacodynamic end points

Por O'Donnell, A, Padhani, A, Hayes, C, Kakkar, A J, Leach, M, Trigo, J M, Scurr, M, Raynaud, F, Phillips, S, Aherne, W, Hardcastle, A, Workman, P, Hannah, A, Judson, I
Publicado em 2005

Combination antiangiogenesis therapy with marimastat, captopril and fragmin in patients with advanced cancer

Por Jones, P H, Christodoulos, K, Dobbs, N, Thavasu, P, Balkwill, F, Blann, A D, Caine, G J, Kumar, S, Kakkar, A J, Gompertz, N, Talbot, D C, Ganesan, T S, Harris, A L
Publicado em 2004